AdaptHealth Corp.AHCO

AdaptHealth Corp. (AHCO) filed an 8-K on July 20, 2026, disclosing an asset purchase agreement with RGH Enterprises, LLC, covering healthcare products and services valued over $250,000 annually. This follows a turbulent Q1 where the company reported $819.8M in revenue but a net loss of $16.0M, with diluted EPS at -$0.12. Liabilities stood at $2.91B against $4.42B in assets, raising questions about leverage in its healthcare-at-home model.

AHCO’s core business revolves around distributing medical equipment and services, touting 'patient-centered' care. However, operational costs bit deeply: operating income barely scraped $5.5M, while capital expenditures hit $121.2M. Inventory increased $7.8M to $159.3M, suggesting either growth preparation or a bet on bulk toilet paper demand. The company’s weighted average shares outstanding rose to 135.8M, diluting retail holders as insiders filed multiple Form 4s in June and July.

The July 20 press release emphasized 'expected revenue growth' and 'adjusted EBITDA margins,' though no concrete figures were provided. With net cash from operations at $93.7M and no buyback program disclosed, investors are left to ponder how AHCO balances acquisition appetite with cash preservation. The lack of guidance in recent filings adds fog to near-term visibility.

Chart-wise, no specific levels are cited in the evidence, but the stock’s price-to-tangible-book ratio would be a logical check given the $1.51B in stockholders’ equity versus $2.91B in liabilities. The company’s ability to convert inventory to cash without further dilution remains a key tension point.